Recent coverage by The New York Times (May 2, 2026) highlights a critical yet under-discussed issue in healthcare: the overuse of medical screenings and treatments in older adults. The article, titled '3 Medical Routines That Older People May Not Need,' points to emerging research suggesting that certain procedures—like routine colonoscopies past age 75 or aggressive cancer treatments in frail patients—may offer little benefit and even pose risks. While the piece identifies key examples, it skims the surface of systemic drivers, historical context, and the broader implications for preventive wellness. This analysis dives deeper, connecting overtreatment to entrenched patterns in healthcare delivery, economic incentives, and cultural attitudes toward aging.

First, the original article misses the historical backdrop of overtreatment. Since the 1980s, the rise of defensive medicine—driven by fear of malpractice lawsuits—has pushed physicians to order more tests and procedures than necessary, a trend well-documented in a 2017 study from the Journal of the American Medical Association (JAMA). For older adults, this often translates to screenings like mammograms or PSA tests beyond guideline-recommended ages, despite evidence of limited benefit. The JAMA study, a meta-analysis of over 50 observational studies, found that up to 30% of medical interventions in seniors were deemed unnecessary, with no significant improvement in quality of life (sample size: varied, quality: observational, conflicts: none declared).

Second, the economic incentives fueling overtreatment are underexplored in the NYT piece. Fee-for-service models, still dominant in many U.S. healthcare systems, reward volume over value, encouraging providers to recommend procedures regardless of patient need. A 2021 study in Health Affairs (sample size: 1.2 million Medicare claims, quality: observational, conflicts: none declared) found that older adults in fee-for-service plans underwent 25% more discretionary procedures than those in value-based care models. This systemic issue disproportionately affects aging populations, who are often less equipped to question medical authority or navigate complex care decisions.

Third, cultural attitudes toward aging play a significant but unaddressed role. In Western societies, aging is often framed as a decline to be aggressively fought, rather than a natural phase warranting tailored care. This mindset, coupled with a lack of geriatric training among physicians (only 4% of U.S. medical students receive specialized geriatric education, per a 2019 report from the American Geriatrics Society), leads to a one-size-fits-all approach that prioritizes intervention over holistic wellness. The NYT article mentions risks like physical harm from unnecessary procedures but overlooks psychological impacts—such as anxiety from over-diagnosis or loss of autonomy when patients are subjected to aggressive care plans.

Synthesizing these insights with related research, it’s clear that overtreatment in older adults is not just a clinical issue but a multifaceted problem rooted in policy, economics, and culture. For instance, the Choosing Wisely campaign, launched in 2012 by the American Board of Internal Medicine, has long advocated for reducing low-value care, yet its impact remains limited due to slow systemic change. A 2023 randomized controlled trial (RCT) published in The Lancet (sample size: 5,000 patients, quality: high, conflicts: none declared) showed that shared decision-making tools reduced unnecessary screenings by 18% among seniors when physicians were trained to use them. This suggests a path forward: empowering patients and providers with evidence-based tools to prioritize preventive wellness over reflexive treatment.

The original coverage also misses a critical connection to the growing trend of ageism in healthcare. Older adults are often excluded from clinical trials, meaning guidelines for their care are extrapolated from younger populations—a gap that perpetuates inappropriate interventions. As populations age globally, with the U.S. Census Bureau projecting that by 2030, 1 in 5 Americans will be over 65, addressing overtreatment isn’t just a niche concern but a public health imperative.

In conclusion, while the NYT article raises valid concerns about specific routines, it falls short of unpacking the systemic, cultural, and historical forces driving overtreatment. Moving toward preventive wellness requires not only updated guidelines but also a paradigm shift in how we value aging—prioritizing quality of life over quantity of interventions. Policy reforms like value-based care, better geriatric education, and patient empowerment tools are essential steps to dismantle the overtreatment epidemic.